The presence of resistance‐associated mutations in reverse transcriptase gene is associated with cerebrospinal fluid HIV‐1 escape: A multicentric retrospective analysis. Issue 4 (3rd April 2023)

• Record Type: Journal Article
• Authors: Trunfio, Mattia; Pinnetti, Carmela; Arsuffi, Stefania; Bai, Francesca; Celani, Luigi; D'Ettorre, Gabriella; Vera, Jaime H.; D'Arminio Monforte, Antonella; Focà, Emanuele; Ghisetti, Valeria; Bonora, Stefano; Antinori, Andrea; Calcagno, Andrea
• Is Part Of: Journal of medical virology. Volume 95:Issue 4(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2023-04-03
• Subjects: central nervous system penetration effectiveness score -- cerebrospinal fluid viral escape -- dual therapy -- genotype resistance testing -- resistance‐associated mutations -- reverse transcriptase; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.28704
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract: Higher risk of cerebrospinal fluid escape (CVE) has been associated with the use of specific antiretroviral (ARV) classes, such as protease inhibitors. We assessed whether archived resistance‐associated mutations (RAMs) can mediate this relationship by identifying patients treated with incompletely active antiretroviral regimens. A retrospective multicentric study on 282 adult people with HIV on antiretroviral therapy (ART) and available historical plasma genotype resistance testing (HGRT) for reverse transcriptase (RT) and protease genes between 2001 and 2021. The odds ratio for demographic, clinic‐, and ART‐related variables and CVE was estimated by multivariable modeling. HGRT‐adjusted central nervous system effectiveness penetration (CPE) score was computed in modeling the risk. Median age, plasma VL, and CD4 count were 49 years, <50 copies/mL, and 310 cells/μL. CVE was detected in 51 participants (17.0%). No difference in CVE prevalence was observed according to ART type, number of ARVs or ARV classes. Participants with CVE had more frequently plasma (52.9% vs. 32.1%, p = 0.005) and CSF RAMs in RT ( n = 63, 57.1% vs. 28.6%, p = 0.029), but not in protease gene. The presence of plasma RAMs in RT associated with increased odds of CVE in adjusted analyses (aOR 3.9, p < 0.001) and in models restricted to plasma viral load ≤50 copies/mL ( n = 202; aOR 4.3, p = 0.003). CVE risk decreased by 40% per each point increase in HGRT‐adjusted CPE score in multivariable models ( p < 0.001). Rather than the type of ARV classes or of ART regimens, functional mono or dual regimens caused by the presence of RAMs affecting ART components may explain the majority of cases of CVE.